News & Clinical Trials: Structural

Apr 22nd, 2022

Clinical Interest Article

ADAPT-TAVR Trial—Coverage of ACC.22

Routine Use of Edoxaban Post-TAVR in Patients Without an Indication for Anticoagulation Does Not Significantly Reduce Valve Thrombosis or Stroke ...

Apr 22nd, 2022

Clinical Interest Article

SURTAVI at 5 Years—Coverage of ACC.22

Self-Expanding TAVR in Intermediate-Risk Patients Non-Inferior to SAVR at 5 Years

Apr 7th, 2022

Clinical Interest Article

Clinical Impact of Residual Leaks Following Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry—Coverage of ACC.22

Apr 7th, 2022

Clinical Interest Article

Tricuspid Valve Repair With Edwards Pascal Transcatheter Repair System at 1 year: CLASP TR—Coverage of ACC.22

Mar 4th, 2022

Clinical Interest Article

Real-World Outcomes With Watchman FLX: Early Results From Surpass—Coverage of CRT 2022

Mar 4th, 2022

Clinical Interest Article

Transcatheter Mitral Cerclage Ventriculoplasty—Coverage of CRT 2022

Mar 3rd, 2022

Clinical Interest Article

Low-Risk TAVR Trial 4-Year Results—Coverage of CRT 2022

Mar 3rd, 2022

Clinical Interest Article

Comparisons of Transcaval and Transaxillary TAVR Alternative Access Routes—Coverage of CRT 2022

Nov 15th, 2021

Clinical Interest Article

CHOICE-CLOSURE—Additional Coverage of TCT 2021

Randomized trial of plug-based closure device versus suture-based closure after TAVR shows mixed results.

Nov 15th, 2021

Clinical Interest Article

SURTAVI at 5-Years—Additional Coverage of TCT 2021

Self-expanding TAVR in intermediate risk patients non-inferior to SAVR at 5 years.

Structural